Cellular and subcellular specialization enables biology-constrained deep learning.

bioRxiv

Center for Advanced Biotechnology and Medicine and Department of Neuroscience and Biology, Rutgers Biomedical and Health Sciences, Rutgers, The State University of New Jersey, Piscataway, NJ 08854.

Published: May 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Learning and memory in the brain depend on changes in the strengths of synaptic connections between neurons. While the molecular and cellular mechanisms of synaptic plasticity have been extensively studied experimentally, much of our understanding of how plasticity is organized across populations of neurons during task learning comes from training artificial neural networks (ANNs) using computational methods. However, the architectures of modern ANNs and the algorithms used to train them are not compatible with fundamental principles of neuroscience, leaving a gap in understanding how the brain coordinates learning across multiple layers of neural circuitry. Here we leverage recent experimental evidence to test an emergent theory that biological learning depends on specialization of distinct neuronal cell types and compartmentalized signaling within neuronal dendrites. We demonstrate that multilayer ANNs comprised of separate recurrently connected excitatory and inhibitory cell types, and neuronal units with separate soma and dendrite compartments, can be trained to accurately classify images using a fully biology-compatible deep learning algorithm called . By adhering to strict biological constraints, this model is able to provide unique insight into the biological mechanisms of learning and to make experimentally testable predictions regarding the roles of specific neuronal cell types in coordinating learning across different brain regions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12154792PMC
http://dx.doi.org/10.1101/2025.05.22.655599DOI Listing

Publication Analysis

Top Keywords

cell types
12
learning
8
deep learning
8
neuronal cell
8
cellular subcellular
4
subcellular specialization
4
specialization enables
4
enables biology-constrained
4
biology-constrained deep
4
learning learning
4

Similar Publications

Passivating detrimental defects is essential for improving perovskite solar cells (PSCs) performance. While hydrogen interstitials are often considered harmful, their role in defect passivation remains unclear. Using nonadiabatic molecular dynamics, we uncover a self-passivation mechanism between hydrogen (H) and bromine (Br) interstitials in all-inorganic CsPbBr perovskites.

View Article and Find Full Text PDF

Background: The aim of this study was to establish a rat model of premature ovarian failure (POF) with cyclophosphamide (CTX), and explore the molecular basis of POF and the mechanism of Guishen-Erxian Decoction (GSEXD) to improve POF from the perspective of oxidative stress regulation of ovarian granulosa cell (OGC) DNA fragmentation.

Method: The study utilized SD rats to establish a POF model via CTX. Rats were divided into Control, POF group, three GSEXD dosage groups (low, medium, high), and a GSEXD+PI3K agonist group to assess GSEXD's therapeutic effects on oxidative stress, DNA fragmentation and ovarian damage.

View Article and Find Full Text PDF

Idiopathic multicentric Castleman disease (iMCD) is a rare lymphoproliferative disorder characterized by systemic inflammation and lymphadenopathy. Two major clinical subtypes, idiopathic plasmacytic lymphadenopathy (iMCD-IPL) and iMCD with thrombocytopenia, anasarca, fever, renal dysfunction/reticulin fibrosis, and organomegaly (iMCD-TAFRO), exhibit distinct pathophysiologic mechanisms. While interleukin-6 (IL-6) is known to be elevated in iMCD, the differences in IL-6 production sources between subtypes remain unclear.

View Article and Find Full Text PDF

IGLV3-21-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemia.

Haematologica

September 2025

Division of Medical Oncology, University Hospital Basel, Basel, Switzerland; Laboratory of Translational Immuno-Oncology, Department of Biomedicine, University and University Hospital Basel, Basel.

We previously used a disease-specific B cell receptor (BCR) point mutation (IGLV3-21R110) for selective targeting of a high-risk subset of chronic lymphocytic leukemia (CLL) with chimeric antigen receptor (CAR) T cells. Since CLL is a disease of the elderly and a significant fraction of patients is not able to physically tolerate CAR T cell treatment, we explored bispecific antibodies as an alternative for precision targeting of this tumor mutation. Heterodimeric IgG1-based antibodies consisting of a fragment crystallizable region (Fc) attached to both an anti-IGLV3-21R110 Fab and an anti-CD3 (UCHT1) single chain variable fragment (R110-bsAb) selectively killed cell lines engineered to express high levels of the neoepitope as well as primary CLL cells using healthy donor and CLL patient-derived T cells as effectors.

View Article and Find Full Text PDF

Immunotherapies, including cell therapies, are effective anti-cancer agents. However, cellular product persistence can be limiting with short functional duration of activity contributing to disease relapse. A variety of manufacturing protocols are used to generate therapeutic engineered T-cells; these differ in techniques used for T-cell isolation, activation, genetic modification, and other methodology.

View Article and Find Full Text PDF